Presentation is loading. Please wait.

Presentation is loading. Please wait.

Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,

Published byMildred Franklin Modified over 6 years ago

Similar presentations

Presentation on theme: "Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,"— Presentation transcript:

1 Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy, MD, Dariush Mozaffarian, MD, DrPH, David T. Linker, MD, David J. Farrar, PhD, Leslie W. Miller, MD  The Journal of Heart and Lung Transplantation  Volume 28, Issue 3, Pages (March 2009) DOI: /j.healun Copyright © 2009 International Society for Heart and Lung Transplantation Terms and Conditions

2 Figure 1 The Seattle Heart Failure Score (SHFS) for patients in the original Seattle Heart Failure Model cohort are rounded to the closest integer from 0 to 4 and stratified by NYHA class. Within each NYHA class, the SHFS provided additional risk stratification. For any given SHFS, the risk of death was similar for NYHA Class II, III or IV heart failure patients. The percent of patients with SHFS 3 or 4 (>40% annual mortality) is shown for each NYHA class. The Journal of Heart and Lung Transplantation  , DOI: ( /j.healun ) Copyright © 2009 International Society for Heart and Lung Transplantation Terms and Conditions

3 Figure 2 The number of REMATCH patients in each 10% grouping of 1-year survival with medical therapy as estimated by the Seattle Heart Failure Model. The Journal of Heart and Lung Transplantation  , DOI: ( /j.healun ) Copyright © 2009 International Society for Heart and Lung Transplantation Terms and Conditions

4 Figure 3 Kaplan–Meier survival curve with the Seattle Heart Failure Score assuming medical management is rounded to the nearest integer from 3 to 5. (a) Survival in the medical group. (b) Survival in the LVAD group, which improved. The Journal of Heart and Lung Transplantation  , DOI: ( /j.healun ) Copyright © 2009 International Society for Heart and Lung Transplantation Terms and Conditions

5 Figure 4 Kaplan–Meier survival curves for the LVAD and medical groups stratified by (a) high-, (b) moderate- and (c) low-risk tertiles of the Seattle Heart Failure Score. The Journal of Heart and Lung Transplantation  , DOI: ( /j.healun ) Copyright © 2009 International Society for Heart and Lung Transplantation Terms and Conditions

Download ppt "Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,"

Similar presentations

Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard.

Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard.
Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.
Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,

Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,
Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,

Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,
Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I

Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I
Evan P. Kransdorf, MD, PhD, Michelle M. Kittleson, MD, PhD, Jignesh K

Evan P. Kransdorf, MD, PhD, Michelle M. Kittleson, MD, PhD, Jignesh K
Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:
Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.
Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device  David Dobarro, MD, Marian Urban, MD, Karen.

Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device  David Dobarro, MD, Marian Urban, MD, Karen.
James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L

James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L
Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with.

Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with.
Jennifer A. Cowger, MD, Matthew A

Jennifer A. Cowger, MD, Matthew A
The Registry of the International Society for Heart and Lung Transplantation: Twenty- seventh official adult heart transplant report—2010  Josef Stehlik,

The Registry of the International Society for Heart and Lung Transplantation: Twenty- seventh official adult heart transplant report—2010  Josef Stehlik,
The Journal of Heart and Lung Transplantation

The Journal of Heart and Lung Transplantation
Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study  Waldemar.

Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study  Waldemar.
Low vitamin D levels are associated with increased rejection and infections after lung transplantation  Erin M. Lowery, MD, Bradford Bemiss, MD, Thomas.

Low vitamin D levels are associated with increased rejection and infections after lung transplantation  Erin M. Lowery, MD, Bradford Bemiss, MD, Thomas.
Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates  Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried.

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates  Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried.
Boot Camp for Ventricular Assist Device Patient Recovery beyond Medical Management  E.A. Hamad, V. Devlin, K. McDonnell, N. Robinson, M. Welsh, E. Kerr,

Boot Camp for Ventricular Assist Device Patient Recovery beyond Medical Management  E.A. Hamad, V. Devlin, K. McDonnell, N. Robinson, M. Welsh, E. Kerr,
Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:

Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 

Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 

Similar presentations

Ads by Google